Christine Y Lu

Summary

Affiliation: Harvard Medical School and Harvard Pilgrim Health Care
Country: USA

Publications

  1. doi request reprint Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function?
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
    Breast 22:482-7. 2013
  2. doi request reprint Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 33:135-44. 2011
  3. doi request reprint Determinants of patient-reported medication errors: a comparison among seven countries
    C Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Int J Clin Pract 65:733-40. 2011
  4. doi request reprint The importance of high-quality evidence of the long-term impact of nonfatal events used in randomized controlled trials: a case study of prasugrel
    C Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Pharmacol Ther 90:27-9. 2011
  5. doi request reprint New users of antidepressant medications: first episode duration and predictors of discontinuation
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and the Harvard Pilgrim Health Care Institute, 133 Brookline Ave, 6th Floor, Boston, MA, 02215, USA
    Eur J Clin Pharmacol 68:65-71. 2012
  6. pmc Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study
    Michael R Law
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 32:729-41; discussion 716. 2010
  7. pmc Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA
    Psychiatr Serv 62:186-93. 2011
  8. doi request reprint Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Med Care 48:4-9. 2010
  9. pmc Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007
    Christine Y Lu
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
    BMC Health Serv Res 8:75. 2008

Detail Information

Publications9

  1. doi request reprint Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function?
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
    Breast 22:482-7. 2013
    ..This study examined rates of cardiac function assessment and predictors of assessment among patients receiving trastuzumab for HER2+ metastatic breast cancer treatment in routine clinical care...
  2. doi request reprint Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 33:135-44. 2011
    ..Some Medicaid programs have adopted prior-authorization (PA) policies that require prescribers to request approval from Medicaid before prescribing drugs not included on a preferred drug list...
  3. doi request reprint Determinants of patient-reported medication errors: a comparison among seven countries
    C Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Int J Clin Pract 65:733-40. 2011
    ..This study compared the predictors of error among seven countries (Australia, Canada, New Zealand, the United Kingdom, the United States, Germany and the Netherlands)...
  4. doi request reprint The importance of high-quality evidence of the long-term impact of nonfatal events used in randomized controlled trials: a case study of prasugrel
    C Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Pharmacol Ther 90:27-9. 2011
    ..This article provides insights into the importance and challenges of using such evidence through the case study of nonfatal myocardial infarction (MI) and nonfatal bleeding with prasugrel...
  5. doi request reprint New users of antidepressant medications: first episode duration and predictors of discontinuation
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and the Harvard Pilgrim Health Care Institute, 133 Brookline Ave, 6th Floor, Boston, MA, 02215, USA
    Eur J Clin Pharmacol 68:65-71. 2012
    ..Clinical guidelines recommend that antidepressant treatment should be continued for at least 6 months. We examined persistence in patients initiated on an antidepressant medication and factors associated with treatment cessation...
  6. pmc Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study
    Michael R Law
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
    Clin Ther 32:729-41; discussion 716. 2010
    ..However, little is known about the impact of these policies on the use of antihypertensive medicines in the United States...
  7. pmc Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA
    Psychiatr Serv 62:186-93. 2011
    ..This study examined the association between a Medicaid prior-authorization policy for second-generation antipsychotic and anticonvulsant agents and medication discontinuation and health service use by patients with bipolar disorder...
  8. doi request reprint Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness
    Christine Y Lu
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Med Care 48:4-9. 2010
    ..The objective of this study was to examine the impact of a Maine Medicaid PA policy on initiation and switching of anticonvulsant and atypical antipsychotic treatments among patients with bipolar disorder...
  9. pmc Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007
    Christine Y Lu
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
    BMC Health Serv Res 8:75. 2008
    ..The objective of this research was to update a previous systematic review of interventions, published between 1966 and 2001, to improve the quality and efficiency of medication use in the US managed care setting...